# Genevieve M. Boland

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/genevieve-m-boland/

## Facts

| Field | Value |
| --- | --- |
| Citations | 30,017 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 70 |
| i10-index | 154 |
| Last Known Institution | Broad Institute |
| OpenAlex ID | https://openalex.org/A5009222009 |
| ORCID iD | https://orcid.org/0000-0002-7522-6173 |
| Works | 818 |

## Researcher papers

- [Genomic Classification of Cutaneous Melanoma](https://scholariq.org/papers/genomic-classification-of-cutaneous-melanoma/)
- [Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma](https://scholariq.org/papers/defining-t-cell-states-associated-with-response-to-checkpoint-immunotherapy-in/)
- [Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study](https://scholariq.org/papers/clinical-impact-of-covid-19-on-patients-with-cancer-ccc19-a-cohort-study/)
- [A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade](https://scholariq.org/papers/a-cancer-cell-program-promotes-t-cell-exclusion-and-resistance-to-checkpoint/)
- [CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation](https://scholariq.org/papers/cdk4-6-inhibition-augments-antitumor-immunity-by-enhancing-t-cell-activation/)
- [The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution](https://scholariq.org/papers/the-human-tumor-atlas-network-charting-tumor-transitions-across-space-and-time/)
- [<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids](https://scholariq.org/papers/i-ex-vivo-i-profiling-of-pd-1-blockade-using-organotypic-tumor-spheroids/)
- [Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma](https://scholariq.org/papers/defining-t-cell-states-associated-with-response-to-checkpoint-immunotherapy-in-2/)
- [Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer](https://scholariq.org/papers/minimal-residual-disease-detection-using-a-plasma-only-circulating-tumor-dna/)
- [Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study](https://scholariq.org/papers/short-term-safety-outcomes-of-mastectomy-and-immediate-implant-based-breast/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Immune cells in cancer](https://scholariq.org/topics/immune-cells-in-cancer/)

## Researcher university

- [Broad Institute](https://scholariq.org/institutions/broad-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.